Search Results 1231-1240 of 17049 for Buspirone

  1. Clinical trials - Oncology (Medical)

    Correlate this measurement with mean lobar absorbed radiation dose and embolic load given to patients and time taken to achieve adequate Future Liver Remnant (> ...

  2. Family-Based Smoking Cessation Alaska Native - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. A Study Of Multiple Therapies In Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of various therapies in patients with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and ...

  4. Arginine (intravenous route) - Side effects & uses - Mayo Clinic

    Arginine injection is used to assess the function of the pituitary gland. It stimulates the pituitary gland to produce growth hormone for the diagnosis of ...

  5. Gadodiamide (intravenous route) - Side effects & uses - Mayo Clinic

    Gadodiamide injection is a magnetic resonance imaging (MRI) contrast agent used to help create a clear picture of the body during an MRI scan. MRI scans use ...

  6. A Study to Evaluate Aspirin for Treating Multiple Sclerosis-related Fatigue - Mayo Clinic

    The purpose of this study is to determine whether aspirin is effective for treatment of fatigue caused by multiple sclerosis (MS). Participation eligibility.

  7. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  8. Tagraxofusp-erzs (intravenous route) - Side effects & uses - Mayo Clinic

    Tagraxofusp-erzs injection is used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN). This medicine is to be given only by or under the direct ...

  9. Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy Or Plus Camizestrant In HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, Or PALB2m Advanced Breast Cancer - Mayo Clinic

    Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy Or Plus Camizestrant In HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ...

  10. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...